KDR and neoplasm: Along with the better understanding of tumor biology, targeted therapy (BCR-ABL, EGFR, VEGFR, HER2, mTOR, c-Met, etc.)and immunotherapy (CTLA-4, PD-1/PD-L1, etc.)have shown exciting anticancer effects in clinic recently.